IL-8 exerts its tumorigenic effects through both
autocrine and paracrine signaling. Secretion of IL-8 by tumor cells can enhance
cell survival and proliferation of the cancer cells through autocrine
signaling. IL-8 also plays an important role in the tumor microenvironment,
which is composed of a diverse group of cells including fibroblasts,
endothelial cells, dendritic cells, and tumor-associated macrophages. A complex
network of cytokines, chemokines, and other inflammatory molecules drives
communication between the microenvironment and the malignant tumor cells (Todorovic-Rakovic and
Milovanovic, 2013). Importantly,
IL-8 is implicated in the initiation of leukocyte infiltration,
neovascularization, and angiogenesis, all processes that precede invasion and
metastasis of tumor cells. Cancer cells secrete IL-8, triggering the
infiltration of leukocytes to the site of chemokine production. Leukocytes in
turn secrete cytokines and growth factors promoting angiogenesis and cell
survival (Gales et al., 2013). more...
Kingfisher Biotech offers many IL-8 products, including recombinant proteins, antibodies, and ELISAs.
Showing posts with label Cancer. Show all posts
Showing posts with label Cancer. Show all posts
Tuesday, September 1, 2015
Saturday, November 9, 2013
IL-34: The brains behind CSF-1R pathology in the brain and skin?
In
humans, loss or gain of function in CSF-1R has been associated with many
inflammatory conditions and cancers, due to its role in the maintenance of
mononuclear phagocytes. In particular, the CSF-1R ligand IL-34 plays a key role
in maintaining the tissue resident macrophages of the skin and brain, thus
being critical to antimicrobial and other inflammatory responses at these
sites. IL-34, along with CSF-1, has also been implicated in the inflammation of
rheumatoid arthritis and Sjögrens, as well as a poor prognosis in many
malignancies. more...
Subscribe to:
Posts (Atom)